Solidified mPEG-PDLLA micelles as a novel oral delivery system of indomethacin

Ouahab Ammar1, Yan Shen, Qi-Neng Ping

  • 1Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.

Insights

Solidified-polymeric micelles effectively encapsulate indomethacin (IND), enhancing its solubility. These IND-loaded micelles show rapid dissolution, making them suitable for tablet and capsule formulations.

Area of Science:

  • Pharmaceutical Technology
  • Materials Science
  • Drug Delivery Systems

Background:

  • Indomethacin (IND) is a nonsteroidal anti-inflammatory drug with limited aqueous solubility.
  • Developing effective drug delivery systems is crucial for improving IND bioavailability and therapeutic efficacy.
  • Polymeric micelles offer a promising platform for encapsulating hydrophobic drugs like IND.

Purpose of the Study:

  • To prepare and characterize indomethacin-loaded solidified-polymeric micelles (IND-SPM).
  • To evaluate the in vitro dissolution properties and solubility enhancement of IND.
  • To assess the suitability of IND-SPM for pharmaceutical formulations such as tablets and capsules.

Main Methods:

  • IND-SPM were prepared using a solution-absorption method followed by rotary evaporation.
  • Methoxy-poly(ethylene glycol)-poly(D, L-lactide) copolymer (mPEG-PDLLA) was utilized as the drug carrier.
  • Polyplasdone XL-10 served as an adsorbent during the preparation process.

Main Results:

  • Over 90% of IND dissolved within 30 minutes from the IND-SPM powder in PBS.
  • Differential Scanning Calorimetry (DSC), 1H Nuclear Magnetic Resonance (NMR), and Scanning Electron Microscopy (SEM) confirmed IND encapsulation within mPEG-PDLLA.
  • A 4.6-fold increase in IND solubility was observed at the highest copolymer concentration.

Conclusions:

  • The prepared IND-SPM demonstrated excellent in vitro dissolution characteristics.
  • The mPEG-PDLLA copolymer effectively encapsulated IND, significantly enhancing its solubility.
  • IND-SPM are suitable for the development of solid dosage forms like tablets and capsules.

Related Concept Videos

Oral Drug Delivery Systems: Delayed-Release Systems01:11

Oral Drug Delivery Systems: Delayed-Release Systems

Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...